Redeye updates its estimates ahead of Arise’s Q2 report, which is due on 17 July. The quarter showed lower market prices for electricity than expected, which has a negative effect on our Q2 estimates. However, Arise has hedged around 25% of our expected Q2 production at favourable prices, which mutes this negative effect. Furthermore, we expect a significant production contribution from the new wind farm Lebo, as well as revenues from ongoing constructions plus the earn-out payment from the finalised project Ranasjö- and Salsjöhöjden in the development segment. The estimate changes do not affect our fair value range or base case.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/